PMID- 24400255 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20140624 LR - 20211021 IS - 2296-2360 (Print) IS - 2296-2360 (Electronic) IS - 2296-2360 (Linking) VI - 1 DP - 2013 May 1 TI - A review of the use of complementary and alternative medicines by children with inflammatory bowel disease. PG - 9 LID - 10.3389/fped.2013.00009 [doi] LID - 9 AB - The Inflammatory Bowel Diseases (IBDs) are diagnosed more commonly in children and adolescents. Following diagnosis, the key objectives are to achieve and then maintain remission. Although some therapies are able to effectively modify and modulate inflammatory events, none of the available interventions cure these conditions. Consequently, children and their parents face uncertainty and may look to alternative management options as ways to help their child, which may include various complementary and alternative medicines (CAMs). A number of studies have shown that many children with IBD receive or are given CAM agents. This article reviews the rates and patterns of CAM use in children with IBD, and emphasizes the increasing importance of these aspects of the management of children with IBD. FAU - Day, Andrew S AU - Day AS AD - Department of Paediatrics, University of Otago Christchurch Christchurch, New Zealand. LA - eng PT - Journal Article PT - Review DEP - 20130501 PL - Switzerland TA - Front Pediatr JT - Frontiers in pediatrics JID - 101615492 PMC - PMC3860894 OTO - NOTNLM OT - Crohn disease OT - children and adolescents OT - communication OT - complementary therapies OT - ulcerative colitis EDAT- 2014/01/09 06:00 MHDA- 2014/01/09 06:01 PMCR- 2013/05/01 CRDT- 2014/01/09 06:00 PHST- 2013/02/23 00:00 [received] PHST- 2013/04/18 00:00 [accepted] PHST- 2014/01/09 06:00 [entrez] PHST- 2014/01/09 06:00 [pubmed] PHST- 2014/01/09 06:01 [medline] PHST- 2013/05/01 00:00 [pmc-release] AID - 10.3389/fped.2013.00009 [doi] PST - epublish SO - Front Pediatr. 2013 May 1;1:9. doi: 10.3389/fped.2013.00009.